Back

NurExone shareholders approve share consolidation of up to 30-for-1

Verifying
  • NurExone shareholders approved all resolutions at the company’s September 15 annual meeting.
  • Shareholders authorized a consolidation of up to 30 pre-Consolidation Shares into one post-Consolidation Share.
  • The Board has 36 months to act, subject to TSXV acceptance and other required approvals.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.